Latham’s Washington, D.C. office offers clients powerhouse corporate capabilities, regulatory insights, as well as litigation and trial strength.
We have built a remarkable track record of navigating the federal government — in the courts, the White House and Executive Branch agencies, as well as Congress. As a group, we draw on experience serving in a wide variety of senior roles within the federal government, so we can advise clients based on deep knowledge of the inner workings of government.
We regularly represent clients facing criminal, civil, and congressional investigations, litigation in all US courts, and the full range of commercial disputes. Our courtroom victories regularly earn Latham recognition from National Law Journal as among the very best litigators and trial lawyers in Washington.
Unique among firms in the capital, we combine classic litigation and regulatory practices with our premier transactional practices, which include the largest and most successful corporate/M&A, capital markets, private equity, and leveraged finance practices in Washington.
As one of the world’s largest pro bono providers, Latham takes on matters in nearly every area of public interest law. In Washington, D.C., some of our key pro bono causes include advocating for asylum seekers, reuniting immigrant and refugee families, and safeguarding tenants’ rights, veterans’ rights, and civil rights.
Partner Matthew Brill, Global Chair of the Connectivity, Privacy, and Information Practice, was named a 2025 Law360 Telecommunications MVP recognized for handling some of the most high-stakes, precedent-setting matters within the telecommunications industry — both in the boardroom and in the courtroom.
A Latham Securities and M&A litigation team secured a significant victory on behalf of American Airlines, winning a dismissal with prejudice in the Northern District of Texas of a securities class action against the airline.
Partner Mike Morin, Global Chair of the Intellectual Property Litigation Practice, was named a 2025 Law360 Intellectual Property MVP for securing two jury trial victories in the past 18 months for Sarepta Therapeutics and Abbott Laboratories in major patent disputes involving their signature products.